Cadarette Group

The Cadarette Group (CG) is led by Suzanne M. Cadarette, PhD. Dr. Cadarette is committed to building a premier pharmacoepidemiologic and health services research program focused on health issues that affect older Canadians.

CG Research

Through our research, we aim to reduce the burden of illness in the population due to suboptimal therapy, adverse drug effects and failure to adhere to preventive pharmacotherapy.

Research interests include improving:

pharmacoepidemiologic methods
drug prescribing and pharmacoprevention among seniors
adherence to chronic pharmacotherapy for asymptomatic conditions

Our efforts are currently focused in the area of osteoporosis and fracture prevention.

	Cadarette Group PHARMACOEPIDEMIOLOGY and HEALTH SERVICES RESEARCH
Team Dr. Cadarette Team Members Alumni Publications Presentations Poster Awards Openings Contact Log-in REBUILD Summary Provinces Papers
The Cadarette Group (CG) is led by Suzanne M. Cadarette, PhD. Dr. Cadarette is committed to building a premier pharmacoepidemiologic and health services research program focused on health issues that affect older Canadians. CG Research Through our research, we aim to reduce the burden of illness in the population due to suboptimal therapy, adverse drug effects and failure to adhere to preventive pharmacotherapy. Research interests include improving: pharmacoepidemiologic methods drug prescribing and pharmacoprevention among seniors adherence to chronic pharmacotherapy for asymptomatic conditions Our efforts are currently focused in the area of osteoporosis and fracture prevention.